These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 9664116
1. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells. Yamamoto H, Monden T, Miyoshi H, Izawa H, Ikeda K, Tsujie M, Ohnishi T, Sekimoto M, Tomita N, Monden M. Int J Oncol; 1998 Aug; 13(2):233-9. PubMed ID: 9664116 [Abstract] [Full Text] [Related]
3. Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higashi H, Saitoh S, Taya Y, Yasuda H. Oncogene; 1993 Sep; 8(9):2425-32. PubMed ID: 8395680 [Abstract] [Full Text] [Related]
4. Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells. Iseki H, Ko TC, Xue XY, Seapan A, Hellmich MR, Townsend CM. Surgery; 1997 Aug; 122(2):187-94; discussion 194-5. PubMed ID: 9288122 [Abstract] [Full Text] [Related]
5. G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation. Akiyama T, Sugiyama K, Shimizu M, Tamaoki T, Akinaga S. Jpn J Cancer Res; 1999 Dec; 90(12):1364-72. PubMed ID: 10665655 [Abstract] [Full Text] [Related]
6. Cell cycle control with minimal participation of Cdk2 in a murine fibrosarcoma clone cultured in protein-free medium. Dobashi Y, Chigira M, Shoji M, Wakata Y, Kitagawa M, Tamauchi H, Akiyama T, Kameya T. Biochem Biophys Res Commun; 1997 Mar 27; 232(3):622-5. PubMed ID: 9126324 [Abstract] [Full Text] [Related]
7. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM. Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461 [Abstract] [Full Text] [Related]
8. A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells. Lane ME, Yu B, Rice A, Lipson KE, Liang C, Sun L, Tang C, McMahon G, Pestell RG, Wadler S. Cancer Res; 2001 Aug 15; 61(16):6170-7. PubMed ID: 11507069 [Abstract] [Full Text] [Related]
9. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. Yamamoto H, Monden T, Ikeda K, Izawa H, Fukuda K, Fukunaga M, Tomita N, Shimano T, Shiozaki H, Monden M. Br J Cancer; 1995 Jun 15; 71(6):1231-6. PubMed ID: 7779716 [Abstract] [Full Text] [Related]
10. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Gong J, Ammanamanchi S, Ko TC, Brattain MG. Cancer Res; 2003 Jun 15; 63(12):3340-6. PubMed ID: 12810668 [Abstract] [Full Text] [Related]
11. Chemical inhibitors of cyclin-dependent kinases. Meijer L, Kim SH. Methods Enzymol; 1997 Jun 15; 283():113-28. PubMed ID: 9251015 [No Abstract] [Full Text] [Related]
12. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Choi YH, Lee WH, Park KY, Zhang L. Jpn J Cancer Res; 2000 Feb 15; 91(2):164-73. PubMed ID: 10761703 [Abstract] [Full Text] [Related]
13. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells. Motwani M, Li X, Schwartz GK. Clin Cancer Res; 2000 Mar 15; 6(3):924-32. PubMed ID: 10741717 [Abstract] [Full Text] [Related]
14. Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain. Roublevskaia IN, Polevoda BV, Ludlow JW, Haake AR. Anticancer Res; 2000 Mar 15; 20(5A):3163-7. PubMed ID: 11062738 [Abstract] [Full Text] [Related]
15. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S. Cancer Res; 1997 Apr 15; 57(8):1495-501. PubMed ID: 9108451 [Abstract] [Full Text] [Related]
16. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Choi YH, Zhang L, Lee WH, Park KY. Int J Oncol; 1998 Aug 15; 13(2):391-6. PubMed ID: 9664138 [Abstract] [Full Text] [Related]
17. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Moragoda L, Jaszewski R, Majumdar AP. Anticancer Res; 2001 Aug 15; 21(2A):873-8. PubMed ID: 11396178 [Abstract] [Full Text] [Related]
18. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. Patel V, Senderowicz AM, Pinto D, Igishi T, Raffeld M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS. J Clin Invest; 1998 Nov 01; 102(9):1674-81. PubMed ID: 9802881 [Abstract] [Full Text] [Related]
19. Induction of differentiation accompanies inhibition of Cdk2 in a non-small cell lung cancer cell line. Lee HR, Chang TH, Tebalt MJ, Senderowicz AM, Szabo E. Int J Oncol; 1999 Jul 01; 15(1):161-6. PubMed ID: 10375610 [Abstract] [Full Text] [Related]
20. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells. Kim SG, Kim SN, Jong HS, Kim NK, Hong SH, Kim SJ, Bang YJ. Oncogene; 2001 Mar 08; 20(10):1254-65. PubMed ID: 11313870 [Abstract] [Full Text] [Related] Page: [Next] [New Search]